These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 9505983)

  • 1. Pharmacokinetics of methylprednisolone and prednisolone after single and multiple oral administration.
    Rohatagi S; Barth J; Möllmann H; Hochhaus G; Soldner A; Möllmann C; Derendorf H
    J Clin Pharmacol; 1997 Oct; 37(10):916-25. PubMed ID: 9505983
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetic/pharmacodynamic evaluation of deflazacort in comparison to methylprednisolone and prednisolone.
    Möllmann H; Hochhaus G; Rohatagi S; Barth J; Derendorf H
    Pharm Res; 1995 Jul; 12(7):1096-100. PubMed ID: 7494809
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of itraconazole on the pharmacokinetics of prednisolone and methylprednisolone and cortisol secretion in healthy subjects.
    Lebrun-Vignes B; Archer VC; Diquet B; Levron JC; Chosidow O; Puech AJ; Warot D
    Br J Clin Pharmacol; 2001 May; 51(5):443-50. PubMed ID: 11422002
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Monitoring glucocorticoid therapy: a pharmacokinetic approach.
    Hill MR; Szefler SJ; Ball BD; Bartoszek M; Brenner AM
    Clin Pharmacol Ther; 1990 Oct; 48(4):390-8. PubMed ID: 2225699
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Methylprednisolone versus prednisolone pharmacokinetics in relation to dose in adults.
    Szefler SJ; Ebling WF; Georgitis JW; Jusko WJ
    Eur J Clin Pharmacol; 1986; 30(3):323-9. PubMed ID: 3732369
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plasma concentrations and effects of oral methylprednisolone are considerably increased by itraconazole.
    Varis T; Kaukonen KM; Kivistö KT; Neuvonen PJ
    Clin Pharmacol Ther; 1998 Oct; 64(4):363-8. PubMed ID: 9797792
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A pharmacokinetic comparison of two oral liquid glucocorticoid formulations.
    Kamada AK; Wiener MB; LaVallee NM; Scott MB; Selner JC; Szefler SJ
    Pharmacotherapy; 1997; 17(2):353-6. PubMed ID: 9085328
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sulfate-conjugated methylprednisolone: evaluation as a colon-specific methylprednisolone prodrug and comparison with sulfate-conjugated prednisolone and dexamethasone.
    Kong H; Kim Y; Lee Y; Choi B; Jung S; Jung Y; Kim YM
    J Drug Target; 2009 Feb; 17(2):159-67. PubMed ID: 18988065
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of itraconazole on the pharmacokinetics and pharmacodynamics of oral prednisolone.
    Varis T; Kivistö KT; Neuvonen PJ
    Eur J Clin Pharmacol; 2000 Apr; 56(1):57-60. PubMed ID: 10853878
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Methylprednisolone achieves greater concentrations in the lung than prednisolone. A pharmacokinetic analysis.
    Greos LS; Vichyanond P; Bloedow DC; Irvin CG; Larsen GL; Szefler SJ; Hill MR
    Am Rev Respir Dis; 1991 Sep; 144(3 Pt 1):586-92. PubMed ID: 1892299
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Spinal cord bioavailability of methylprednisolone after intravenous and intrathecal administration: the role of P-glycoprotein.
    Koszdin KL; Shen DD; Bernards CM
    Anesthesiology; 2000 Jan; 92(1):156-63. PubMed ID: 10638912
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of methylprednisolone (1 g i.v.) with prednisolone (1 g orally) in rheumatoid arthritis: a pharmacokinetic and clinical study.
    Needs CJ; Smith M; Boutagy J; Donovan S; Cosh D; McCredie M; Brooks PM
    J Rheumatol; 1988 Feb; 15(2):224-8. PubMed ID: 3361533
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of corticosteroid binding globulin on the pharmacokinetics of prednisolone in rats.
    Ko HC; Almon RR; Jusko WJ
    Pharm Res; 1995 Jun; 12(6):902-4. PubMed ID: 7667198
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Influence of body condition on plasma prednisolone and prednisone concentrations in clinically healthy cats after single oral dose administration.
    Center SA; Randolph JF; Warner KL; Simpson KW; Rishniw M
    Res Vet Sci; 2013 Aug; 95(1):225-30. PubMed ID: 23473553
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lack of pharmacokinetic interaction between St. John's wort and prednisone.
    Bell EC; Ravis WR; Chan HM; Lin YJ
    Ann Pharmacother; 2007 Nov; 41(11):1819-24. PubMed ID: 17925494
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Methylprednisolone pharmacokinetics after intravenous and oral administration.
    Al-Habet SM; Rogers HJ
    Br J Clin Pharmacol; 1989 Mar; 27(3):285-90. PubMed ID: 2655680
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacokinetic study of oral prednisolone compared with intravenous methylprednisolone in patients with juvenile dermatomyositis.
    Rouster-Stevens KA; Gursahaney A; Ngai KL; Daru JA; Pachman LM
    Arthritis Rheum; 2008 Feb; 59(2):222-6. PubMed ID: 18240180
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of an oral contraceptive on the plasma levels of budesonide and prednisolone and the influence on plasma cortisol.
    Seidegård J; Simonsson M; Edsbäcker S
    Clin Pharmacol Ther; 2000 Apr; 67(4):373-81. PubMed ID: 10801246
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Population pharmacokinetics of prednisolone in children with acute lymphoblastic leukemia.
    Petersen KB; Jusko WJ; Rasmussen M; Schmiegelow K
    Cancer Chemother Pharmacol; 2003 Jun; 51(6):465-73. PubMed ID: 12698270
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prednisolone and methylprednisolone kinetics in children receiving anticonvulsant therapy.
    Bartoszek M; Brenner AM; Szefler SJ
    Clin Pharmacol Ther; 1987 Oct; 42(4):424-32. PubMed ID: 3665340
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.